Companies / Santa Cruz Biotechnology / Cytokeratin 18 (DC-10) FITC
Santa Cruz Biotechnology

Cytokeratin 18 (DC-10) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; Cytokeratin 18 Antibody (DC-10) is an IgG1 κ mouse monoclonal Cytokeratin 18 antibody (also designated Cytokeratin 18 antibody or KRT18 antibody) that detects Cytokeratin 18 of human origin by WB, IP, IF and IHC(P). Cytokeratin 18 Antibody (DC-10) is available as the non-conjugated anti-Cytokeratin 18 antibody form, as well as multiple conjugated forms of anti-Cytokeratin 18 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Cytokeratins comprise a diverse group of intermediate filament proteins (IFPs) that are expressed as pairs in both keratinized and non-keratinized epithelial tissue. Cytokeratins play a critical role in differentiation and tissue specialization and function to maintain the overall structural integrity of epithelial cells. Cytokeratins have been found to be useful markers of tissue differentiation which is directly applicable to the characterization of malignant tumors. For example, Cytokeratins 10 and 13 are expressed highly in a subset of squamous cell carcinomas while Cytokeratin 18 is expressed in a majority of adenocarcinomas and basal cell carcinomas. Cytokeratin 18 contains two major phosphorylation sites on Ser 33 and Ser 52. Phosphorylation of Ser 18 is essential for the association of Cytokeratin 18 with 14-3-3 proteins and is involved in keratin organization and distribution.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.